CRDL
Cardiol Therapeutics, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.10
+0.00%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.06
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.04
- EPS estimate
- -$0.09
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +19.4%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $9.50
- PT range
- $9.00 – $10
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.09 | -$0.04 | Beat 55.56% | — |
| May 11, 2026 | -$0.07 | -$0.07 | In line | — |
| Mar 30, 2026 | -$0.09 | -$0.07 | Beat 22.22% | — |
| Nov 13, 2025 | -$0.09 | -$0.09 | In line | — |
| Aug 14, 2025 | -$0.11 | -$0.07 | Beat 36.36% | — |
| Mar 31, 2025 | -$0.08 | -$0.07 | Beat 12.50% | — |
| Nov 14, 2024 | -$0.10 | -$0.13 | Miss -30.00% | — |
| Nov 14, 2023 | -$0.12 | -$0.07 | Beat 41.67% | — |
| Aug 10, 2023 | -$0.12 | -$0.09 | Beat 25.00% | — |
| May 15, 2023 | -$0.15 | -$0.08 | Beat 46.67% | — |
| Nov 10, 2022 | -$0.14 | -$0.10 | Beat 28.57% | — |
| Aug 10, 2022 | -$0.10 | -$0.08 | Beat 20.74% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026